Education
About Us
Working with TipRanks
Follow Us
Blue Jet Healthcare Limited (IN:BLUEJET)
:BLUEJET
BLUEJET Stock Chart & Stats
₹653.45
-₹16.80(-2.80%)
At close: 4:00 PM EST
₹653.45
-₹16.80(-2.80%)
Day’s Range― - ―
52-Week Range₹352.75 - ₹1,028.20
Previous CloseN/A
Volume75.53K
Average Volume (3M)19.19K
Market Cap
₹62.35B
Enterprise Value₹59.92B
Total Cash (Recent Filing)₹3.06B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)21.2
Beta1.07
Next Earnings
May 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.22%
Share Statistics
EPS (TTM)2.30
Shares Outstanding173,465,420
10 Day Avg. Volume15,409
30 Day Avg. Volume19,187
Financial Highlights & Ratios
PEG Ratio0.55
Price to Book (P/B)12.87
Price to Sales (P/S)14.16
P/FCF Ratio-427.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained 45% top-line growth demonstrates durable demand for Blue Jet's APIs and intermediates, expanding scale and bargaining power with suppliers and customers. Over months this supports predictable contract renewals, capacity utilization improvements and reinvestment into higher‑margin specialty molecules.
High And Improving MarginsRobust gross and operating margins reflect efficient manufacturing and a favorable product mix of specialty/niche molecules. These margins are structural advantages that improve cash generation potential, sustain R&D or quality compliance spending, and provide buffer against cyclical price pressure over the medium term.
Very Low Leverage And Strong Equity BaseExtremely low leverage and a high equity ratio provide financial flexibility for capex, compliance investments, or selective M&A without stressing the balance sheet. High ROE indicates efficient capital use, supporting long-term stability and the ability to fund regulated‑market requirements reliably.
Bears Say
Weak Cash Conversion / Negative FCFLow operating cash conversion and a swing to negative free cash flow reduce internal funding for capacity expansion, quality upgrades or working capital. If this persists, the company may need external financing or delay investments, which can constrain growth and operational resilience over several quarters.
Operational Sensitivity To Inputs And UtilizationRevenue and margins depend on raw material prices, manufacturing yields and utilization rates. These structural exposure points can cause durable margin volatility if input costs rise or utilization falls, necessitating continuous efficiency improvements and procurement management to protect long-term profitability.
Opaque Customer / Revenue ConcentrationLack of disclosed customer or segment detail reduces revenue visibility and raises concentration risk: large B2B contracts can be renegotiated or lost. Over months, this opacity makes forecasting renewal risk and dependency on a few counterparties a structural governance and revenue‑stability concern.
Blue Jet Healthcare Limited News
BLUEJET FAQ
What was Blue Jet Healthcare Limited’s price range in the past 12 months?
Blue Jet Healthcare Limited lowest stock price was ₹352.75 and its highest was ₹1028.20 in the past 12 months.
What is Blue Jet Healthcare Limited’s market cap?
Blue Jet Healthcare Limited’s market cap is ₹62.35B.
When is Blue Jet Healthcare Limited’s upcoming earnings report date?
Blue Jet Healthcare Limited’s upcoming earnings report date is May 25, 2026 which is in 91 days.
How were Blue Jet Healthcare Limited’s earnings last quarter?
Blue Jet Healthcare Limited released its earnings results on Feb 13, 2026. The company reported ₹2.3 earnings per share for the quarter, missing the consensus estimate of ₹3.55 by -₹1.25.
Is Blue Jet Healthcare Limited overvalued?
According to Wall Street analysts Blue Jet Healthcare Limited’s price is currently Overvalued.
Does Blue Jet Healthcare Limited pay dividends?
Blue Jet Healthcare Limited pays a Notavailable dividend of ₹1.2 which represents an annual dividend yield of 0.22%. See more information on Blue Jet Healthcare Limited dividends here
What is Blue Jet Healthcare Limited’s EPS estimate?
Blue Jet Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blue Jet Healthcare Limited have?
Blue Jet Healthcare Limited has 173,465,420 shares outstanding.
What happened to Blue Jet Healthcare Limited’s price movement after its last earnings report?
Blue Jet Healthcare Limited reported an EPS of ₹2.3 in its last earnings report, missing expectations of ₹3.55. Following the earnings report the stock price went down -9.998%.
Which hedge fund is a major shareholder of Blue Jet Healthcare Limited?
Currently, no hedge funds are holding shares in IN:BLUEJET
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited (BLUEJET) is a dynamic player in the healthcare sector, focusing on the development and distribution of innovative medical products and services. The company operates primarily in the pharmaceuticals and medical devices sectors, offering a wide range of healthcare solutions designed to enhance patient care and operational efficiency in healthcare facilities. Core products include advanced medical devices, diagnostic tools, and a portfolio of pharmaceutical products aimed at addressing various health conditions.
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
Jubilant Ingrevia Ltd.
―
Supriya Lifescience Limited
―
Syngene International Ltd.
―